Congratulations again Sabelo Lukhele, PhD on your great work! It’s been a fantastic journey!!

I am deeply honoured to have won the very prestigious BD-Biosciences/Immunology Postdoctoral Lecture Award!!!! Thank you BD Biosciences DavidBrooksLab Tania_WattsUoft Temerty Medicine!!! Princess Margaret Cancer Centre Research The Office of Research Trainees (ORT) at UHN Canadian Black Scientists Network UHN Postdoc Association (UHNPA) Postdocs@UofT Immunology

Finally, we’ve reached the Best Country category. It’s an enormous question, but the readers were undeterred. The winner is… South Africa (South African Tourism)! #TeleTravelAwards

Great job Mengdi Guo and colleagues uncovering a mechanism of #CD4 T cell differentiation and dysfunction in the lymph node that impedes tumor control. Important implications for #immunotherapy. Cell Reports University Health Network Princess Margaret Cancer Centre Temerty Medicine tinyurl.com/Guo-et-al

Molecular, metabolic, and functional CD4 T cell paralysis in the lymph node impedes tumor control dlvr.it/SvS018

A cheap malaria vaccine approved!! bbc.com/news/health-66…

Tissue factor binds to and inhibits interferon-α receptor 1 signaling dlvr.it/T19Rrt

Today, the American Cancer Society Society released our 2024 Cancer Facts and Figures report. The data reveal that over 2 million NEW cancer cases are expected to be diagnosed in the U.S. These findings underscore the importance of cancer prevention & screening. pressroom.cancer.org/acs-cff-2024

If you have not voted yet for AACR president- elect do it now! Our amazing Lillian Siu is on the ballot.

#1 hospital in 🇨🇦 Canada 🇨🇦 # 3 hospital in the 🌎 World 🌎 🙌🙌🙌 University Health Network Proud to be part of TeamUHN!!! ⬇️⬇️⬇️

Fantastic insights by Mengdi Guo & Melissa Liu reviewing the regulation and impact of CD4 T cells in #cancer and #immunotherapy. This will be very helpful for the #CD4 T cell and cancer fields! Trends in Immunology University Health Network Princess Margaret Cancer Centre Temerty Medicine authors.elsevier.com/a/1incK5Eb0Rxn…

Can a blood sample be used to predict patient outcomes to #cancer #immunotherapy drug pembrolizumab? Researchers Enrique Sanz-Garcia, Eric Stutheit-Zhao and Lillian Siu from Princess Margaret Cancer Centre Research investigate this in their new study. Read more > uhnresearch.ca/news/assessing…; doi.org/10.1158/2159-8…

Important changes and welcome increases to student scholarships and postdoctoral fellowships. Looks like Banting and Vanier are going away.

Congratulations again Sophie and Matt! You both are beyond amazing!

Congratulations David Kirsch, MD, PhD!!!!

Changing the SOC for #sarcoma patients David Kirsch, MD, PhD 🙏🏾🙏🏾🙏🏾

Congratulations to Princess Margaret Cancer Centre #RMPatPM's Head Dr. David Kirsch David Kirsch, MD, PhD, who presented influential findings on #sarcoma therapy at the 2024 ASCO Annual Meeting

Dr. David Kirsch, MD, PhD, Senior Scientist at Princess Margaret Cancer Centre Research, recently shared about his work to reduce cancer relapse in a sarcoma clinical trial. Read more about the trial below ⬇️ Thank you Stand Up To Cancer for supporting our researchers as they create #AHealthierWorld.

Just in time for #CTOS2024: Thrilled to share SU2C-SARC032 (NCT03092323), a randomized trial of pembrolizumab in Stage 3 extremity soft tissue sarcoma, now published The Lancet! authors.elsevier.com/a/1k5JbV-4XOupH 1/13 SARC Stand Up To Cancer CTOS Radiation Medicine Program Princess Margaret Cancer Centre University Health Network Radiation Oncology

Scientists at Princess Margaret Cancer Centre Research have classified a new subtype of T-cell acute lymphoblastic #leukemia, paving the way for personalized treatment. This discovery could help patients who don’t respond to standard therapy. Read more ➡️ uhnresearch.ca/news/opening-d…